AGP Picks
View all

Aruba Science Wire
Provided by AGP

Aruba Science Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on April 29, 2026

Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
Apr. 29, 2026

Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting

Indeterminate GlobeNewswire
CorTec's Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his Mind
Apr. 29, 2026

CorTec's Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his Mind

Indeterminate GlobeNewswire
Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the Clinic
Apr. 29, 2026

Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the Clinic

Indeterminate GlobeNewswire
SureShotFX Marks Milestone Expansion for Providing Trading Alerts & Automated Tools
Apr. 29, 2026

SureShotFX Marks Milestone Expansion for Providing Trading Alerts & Automated Tools

Indeterminate GlobeNewswire
Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
Apr. 29, 2026

Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders

Indeterminate GlobeNewswire
Roadzen’s drivebuddyAI Wins $2.5 Million Contract to Bring AI-Powered Safety to 3,000 Truck Fleet
Apr. 29, 2026

Roadzen’s drivebuddyAI Wins $2.5 Million Contract to Bring AI-Powered Safety to 3,000 Truck Fleet

Indeterminate GlobeNewswire
Sagtec Global Limited Achieves Record Revenue of US$19.1 Million in Fiscal Year 2025, Marking 49% Year-over-Year Growth
Apr. 29, 2026

Sagtec Global Limited Achieves Record Revenue of US$19.1 Million in Fiscal Year 2025, Marking 49% Year-over-Year Growth

Indeterminate GlobeNewswire
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
Apr. 29, 2026

Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
Apr. 29, 2026

Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution

Indeterminate GlobeNewswire
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
Apr. 29, 2026

OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May

Indeterminate GlobeNewswire
ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026
Apr. 29, 2026

ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026

Indeterminate GlobeNewswire
EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026
Apr. 29, 2026

EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026

Indeterminate GlobeNewswire
Energous to Report First Quarter 2026 Financial Results and Host Conference Call
Apr. 29, 2026

Energous to Report First Quarter 2026 Financial Results and Host Conference Call

Indeterminate GlobeNewswire
Aeluma to Announce Third Quarter Fiscal Year 2026 Financial Results on May 13, 2026
Apr. 29, 2026

Aeluma to Announce Third Quarter Fiscal Year 2026 Financial Results on May 13, 2026

Indeterminate GlobeNewswire
Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)
Apr. 29, 2026

Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)

Indeterminate GlobeNewswire
Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD
Apr. 29, 2026

Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium…
Apr. 29, 2026

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium…

Indeterminate GlobeNewswire
Amarin Reports 2026 First Quarter Financial Results
Apr. 29, 2026

Amarin Reports 2026 First Quarter Financial Results

Indeterminate GlobeNewswire
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
Apr. 29, 2026

Intellia Therapeutics Announces Pricing of Public Offering of Common Stock

Indeterminate GlobeNewswire
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
Apr. 29, 2026

Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Aruba Science Wire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.